System Human Immunology in vaccines

  • Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees at Baseline, and After Immunization with the H1N1 and Seasonal Influenza Vaccines.
  • Characterization of Innate Immune Responses to AS03 Adjuvanted H5N1 Vaccine Compared to Non-Adjuvanted H5N1 Vaccine.
  • Phase I Study of the Safety of Herpes Simplex Virus-2 (HSV-2) 529 Vaccine in Adults Aged 18 to 50 Years with and without HSV Infection.
  • Technology Development

  • Setting up new technologies and platforms
  • Standardizing Flow Cytometry Immunophenotyping Analysis
  • Therapeutics

  • The Safety and Tolerability of Ultra Low Dose Interleukin-2 (Aldesleukin) in Healthy Volunteers
  • Effects of Systemically Administered Hydrocortisone on the Human Immunome